Nanomedicine News

RSS

Tekmira Commences Dosing in TKM-HBV Phase I Clinical Trial for Chronic Hepatitis B Virus Infection

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today that it has dosed the first subject in a Phase I clinical trial of TKM-HBV, a therapeutic agent designed to reduce hepatitis B surface antigen in patients chronically infected with hepatitis B virus (HBV).

22 Jan 2015

Non-Functionalised Carbon Nanotubes May Not Be Blood-Compatible

Scientists in the School of Pharmacy and Pharmaceutical Sciences in Trinity College Dublin, have made an important discovery about the safety issues of using carbon nanotubes as biomaterials which come into contact with blood. The significance of their findings is reflected in their paper being published as the feature story and front page cover of the international, peer-reviewed journal Nanomedicine.

21 Jan 2015

MU Researcher Honored with Hevesy Medal for Contributions to Nanomedicine

Gold nanoparticles have been proven useful in a number of medical applications. Scientists are developing nanoparticles to produce pharmaceuticals used in the imaging and diagnosis of diseases such as cancer, arthritis, Parkinson's disease and eye degeneration.

21 Jan 2015

FDA Grants Fast Track Status for Celator’s CPX-351 to Treat Elderly Patients with Secondary AML

Celator Pharmaceuticals, Inc., a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for CPX-351 (cytarabine:daunorubicin) for the treatment of elderly patients with secondary Acute Myeloid Leukemia (AML).

21 Jan 2015

New, Wearable Nanowire Sensor Monitors Electrophysiological Signals

Researchers from North Carolina State University have developed a new, wearable sensor that uses silver nanowires to monitor electrophysiological signals, such as electrocardiography (EKG) or electromyography (EMG).

21 Jan 2015

Newly Designed Nanoparticle Can Be Detected By Six Medical Imaging Techniques

It's technology so advanced that the machine capable of using it doesn't yet exist.

21 Jan 2015

MIT Researchers Develop Novel Approach for Nanoscale Resolution Microscopy of Large Biological Samples

Researchers from MIT have successfully discovered a technique to physically magnify tissue samples by implanting them in a polymer, which swells on addition with water to enable high-resolution images. Since the late 1500s when the first microscope was invented, scientists have been devising ways to study preserved tissues and cells in a better manner.

From Massachusetts Institute of Technology 20 Jan 2015

Tiny Microfluidic Device Helps Analyze Behavior of Blood from Sickle Cell Disease Patients

Patients with sickle cell disease often suffer from painful attacks known as vaso-occlusive crises, during which their sickle-shaped blood cells get stuck in tiny capillaries, depriving tissues of needed oxygen. Blood transfusions can sometimes prevent such attacks, but there are currently no good ways to predict when a vaso-occlusive crisis, which can last for several days, is imminent.

From Massachusetts Institute of Technology 20 Jan 2015

Cerulean’s CRLX10 Nanoparticle-Drug Conjugate Phase 1b/2 Data Presented at ASCO 2015 Symposium

Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting™, today announced that preclinical data and initial clinical data from a Phase 1b/2 investigator-sponsored trial of CRLX101 in combination with chemoradiotherapy in non-metastatic rectal cancer was presented at the ASCO 2015 Gastrointestinal Cancers Symposium held January 15-17, 2015.

20 Jan 2015

Vicus Presents Two Combination Studies on VT-122 at 2015 Gastrointestinal Cancers Symposium

Vicus Therapeutics, an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, today announced the presentation of two separate studies demonstrating a safety and survival benefit for VT-122, the company's lead compound, when combined with standard-of-care therapy in patients with advanced liver and pancreatic cancers. Results from both studies were presented today at the 2015 Gastrointestinal Cancers Symposium in San Francisco, Calif.

19 Jan 2015

Nanomedicine News

Tekmira Commences Dosing in TKM-HBV Phase I Clinical Trial for Chronic Hepatitis B Virus Infection

Non-Functionalised Carbon Nanotubes May Not Be Blood-Compatible

MU Researcher Honored with Hevesy Medal for Contributions to Nanomedicine

FDA Grants Fast Track Status for Celator’s CPX-351 to Treat Elderly Patients with Secondary AML

New, Wearable Nanowire Sensor Monitors Electrophysiological Signals

Newly Designed Nanoparticle Can Be Detected By Six Medical Imaging Techniques

MIT Researchers Develop Novel Approach for Nanoscale Resolution Microscopy of Large Biological Samples

Tiny Microfluidic Device Helps Analyze Behavior of Blood from Sickle Cell Disease Patients

Cerulean’s CRLX10 Nanoparticle-Drug Conjugate Phase 1b/2 Data Presented at ASCO 2015 Symposium

Vicus Presents Two Combination Studies on VT-122 at 2015 Gastrointestinal Cancers Symposium

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting